title: Heterogeneity of B lineage acute lymphoblastic leukemias (B-ALL) with regard to their in vitro spontaneous proliferation, growth factor response and BCL-2 expression.
abstract: The spontaneous proliferation and the effects of 8 various growth factors (GF) were evaluated on leukemic cells from 27 patients with B-lineage ALL. Two groups of ALLs were distinguished. ALLs from group I (21 patients) exhibited a low spontaneous proliferative rate and were stimulated by IL-3 + IL-7 +/- SCF and/or LIF, while ALLs from group II (6 patients) had a high spontaneous proliferative rate and did no longer require this combination of GFs for proliferation. No effect of bFGF, IGF-I, IL-10 and IL-11 alone or in combination, was observed. Such differences in the behaviour of B-ALLs indicated that the GF requirement of ALL blasts was not related to the presence of serum in the culture nor to the pattern of reactivity of ALL blasts for B lymphoid markers or CD34 antigen. Furthermore, we showed in 1/9 cases that high proliferation might be due to an overexpression of the bcl-2 proto-oncogene and to the acquisition of an autocrine secretion.
authors.affiliation: Department of Hematology, Faculté de Médecine Saint Antoine, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Pontvert-Delucq
authors.forename: U
authors.initials: U
authors.lastname: Hibner
authors.forename: E
authors.initials: E
authors.lastname: Vilmer
authors.forename: C
authors.initials: C
authors.lastname: Baillou
authors.forename: P
authors.initials: P
authors.lastname: Rohrlich
authors.forename: D
authors.initials: D
authors.lastname: Heymann
authors.forename: A
authors.initials: A
authors.lastname: Najman
authors.forename: M
authors.initials: M
authors.lastname: Guigon
authors.forename: F M
authors.initials: FM
authors.lastname: Lemoine
mesh_terms: D000328:Adult; D017209:Apoptosis / Q000187:drug effects; D002051:Burkitt Lymphoma / Q000378:metabolism* / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000494:pharmacology*; D005260:Female; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D007223:Infant; D008297:Male; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis*; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D016207:Cytokines; D006133:Growth Substances; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger